Depression Clinical Trials in Chicago

Showing 101-120 of 229 trials

Evaluation of Text Message Engagement Support of Mindfulness Smartphone Applications

NCT03633682

The aim of this study is to assess the usability of two mindfulness smartphone applications (apps) and to evaluate whether text message support can promote engagement with those apps through a 4-week trial comparing support vs. no support.

DepressionAnxiety

Northwestern University40 participantsStarted Jun 2018

Chicago, Illinois, United States

COMPLETEDPhase 32.2 miles

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

NCT00483548

The purpose of this study is to determine if a treatment regimen of ziprasidone plus a mood stabilizer is safe and effective in the short term treatment of Bipolar I Depression. Ziprasidone will be added to lithium, valproate or lamotrigine after the patient has been on a therapeutic dose of one of these mood stabilizers for at least 4 weeks.

Bipolar DisorderDepression, Bipolar

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.298 participantsStarted Oct 2007

Chandler, Arizona, United States • Litchfield Park, Arizona, United States • Little Rock, Arkansas, United States +67 more locations

Evaluation of Text Message Engagement Support of Mindfulness Smartphone Applications

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

Depression Trials in Other Cities

An Expert System to Reduce Depression in Primary Care

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder

Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness

IntelliCare in College Students

A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression

Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder

SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

rTMS for Depressed Teens: A Sham-Controlled Trial, Part 2

A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder

Clinical Evaluation of Flortaucipir F 18

Assessing Symptomatic Clinical Episodes in Depression

Other Conditions in Chicago